Reactive oxygen intermediates in TNF signaling

Amit K Garg1, Bharat B Aggarwal

  • 1Department of Bioimmunotherapy, The Cytokine Research Laboratory, Box 143, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

Molecular Immunology
|November 15, 2002
PubMed

Insights

Tumor necrosis factor (TNF) triggers cell signals like apoptosis and gene transcription. Reactive oxygen intermediates (ROI) are key to TNF signaling, mediating both cell survival and death.

Area of Science:

  • Cellular signaling pathways
  • Molecular biology
  • Biochemistry

Background:

  • Tumor necrosis factor (TNF) is a potent inducer of critical intracellular signals.
  • TNF activates pathways including caspases, kinases (MAPK, JNK), and transcription factors (AP-1, NF-kappaB).
  • TNF signaling involves both pro-apoptotic and pro-survival mechanisms.

Purpose of the Study:

  • To review evidence linking reactive oxygen intermediates (ROI) to TNF-induced signaling.
  • To explore the role of ROI in mediating TNF's diverse cellular effects.
  • To understand the balance of ROI in maintaining cellular homeostasis.

Main Methods:

  • Literature review of studies on TNF signaling and ROI.
  • Analysis of molecular mechanisms connecting ROI to TNF pathways.
  • Synthesis of evidence regarding ROI's dual role in apoptosis and survival.

Main Results:

  • Reactive oxygen intermediates (ROI) are implicated in TNF-mediated intracellular signaling.
  • ROI appear to mediate both pro-apoptotic and pro-survival signals induced by TNF.
  • The precise mechanisms balancing these opposing ROI effects remain unclear.

Conclusions:

  • ROI play a significant role in the complex intracellular signaling initiated by TNF.
  • Understanding the dual role of ROI in TNF signaling is crucial for deciphering cellular fate.
  • Further research is needed to elucidate how ROI-mediated antagonistic signals are regulated for homeostasis.

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...